알라딘

헤더배너

약물 가이드

이주의 저자랭킹

  1. 1위
    리처드 도킨스

    <이기적 유전자>, <만들어진 신>, <이기적 유전자>

  3. 2.맥스 베넷
  5. 3.Joseph E. Muscolino
  7. 4.올리버 색스
  9. 5.Inna Segal
신간알림

베스트셀러: 최근 일주일간 가장 많이 판매된 도서입니다.
검색 rss

1.  
 
Malware's Malevolent Matrix: Deciphering the complex algorithms that drive destructive malware (Paperback)
Hadley Kingsley | Hadley Kingsley
45,180원(18% 할인 / 2,260원)
2.  
 
Ethno botanical Explorations: Uncovering Traditional Medicine's Enduring Impact On Global Health (Paperback)
Naomi Oneal | Naomi Oneal
51,200원(18% 할인 / 2,560원)
3.  
 
Tramadol and Pain Management: Understanding Its Benefits, Risks, and Safe Use (Paperback)
Franklin Higgins | Independently Published
15,060원(18% 할인 / 760원)
4.  
 
Sildenafil for Men 100mg (Paperback)
Nirmit Nirav | Notion Press
16,550원(18% 할인 / 830원)

5.  
 
ZTALMY (ganaxolone) Drug Profile, 2025: ZTALMY (ganaxolone) drug patents, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
6.  
 
ZERBAXA (ceftolozane sulfate; tazobactam sodium) Drug Profile, 2025: ZERBAXA (ceftolozane sulfate; tazobactam sodium) drug patents, SPCs, clinical tri (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
7.  
 
ZEPZELCA (lurbinectedin) Drug Profile, 2025: ZEPZELCA (lurbinectedin) drug patents, clinical trials, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
8.  
 
ZEPOSIA (ozanimod hydrochloride) Drug Profile, 2025: ZEPOSIA (ozanimod hydrochloride) drug patents, SPCs, clinical trials, drug prices, suppliers, API (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

9.  
 
ZEMDRI (plazomicin sulfate) Drug Profile, 2025: ZEMDRI (plazomicin sulfate) drug patents, litigation, clinical trials, drug prices, suppliers, API sou (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
10.  
 
ZELSUVMI (berdazimer sodium) Drug Profile, 2025: ZELSUVMI (berdazimer sodium) drug patents (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
11.  
 
YUPELRI (revefenacin) Drug Profile, 2025: YUPELRI (revefenacin) drug patents, litigation, clinical trials, drug prices, drug prices, suppliers, API so (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
12.  
 
ZEJULA (niraparib tosylate) Drug Profile, 2025: ZEJULA (niraparib tosylate) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, A (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

13.  
 
XYWAV (calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate) Drug Profile, 2025: XYWAV (calcium oxybate; magnesium oxybate; potassium (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
14.  
 
XTAMPZA ER (oxycodone) Drug Profile, 2025: XTAMPZA ER (oxycodone) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
15.  
 
XPOVIO (selinexor) Drug Profile, 2025: XPOVIO (selinexor) drug patents, SPCs, clinical trials, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
16.  
 
XOPENEX HFA (levalbuterol tartrate) Drug Profile, 2025: XOPENEX HFA (levalbuterol tartrate) drug patents, litigation, clinical trials, drug prices, an (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

17.  
 
XIGDUO XR (dapagliflozin; metformin hydrochloride) Drug Profile, 2025: XIGDUO XR (dapagliflozin; metformin hydrochloride) drug patents, patent challen (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
18.  
 
XIFAXAN (rifaximin) Drug Profile, 2025: XIFAXAN (rifaximin) drug patents, patent challenges, litigation, clinical trials, drug prices, annual drug sam (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
19.  
 
XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, A (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
20.  
 
XELSTRYM (dextroamphetamine) Drug Profile, 2025: XELSTRYM (dextroamphetamine) drug patents, litigation, drug prices, drug prices, suppliers, API sourc (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

21.  
 
XCOPRI (cenobamate) Drug Profile, 2025: XCOPRI (cenobamate) drug patents, SPCs, clinical trials, drug prices, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
22.  
 
WAKIX (pitolisant hydrochloride) Drug Profile, 2025: WAKIX (pitolisant hydrochloride) drug patents, litigation, SPCs, drug prices, suppliers, API sour (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
23.  
 
UBRELVY (ubrogepant) Drug Profile, 2025: UBRELVY (ubrogepant) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
24.  
 
TYMLOS (abaloparatide) Drug Profile, 2025: TYMLOS (abaloparatide) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

25.  
 
TRULANCE (plecanatide) Drug Profile, 2025: TRULANCE (plecanatide) drug patents, litigation, PTAB cases, clinical trials, drug prices, suppliers, API s (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
26.  
 
TRIUMEQ PD (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: TRIUMEQ PD (abacavir sulfate; dolutegravir sodium; lamivudine) drug (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
27.  
 
TRIUMEQ (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: drug patents, patent challenges, litigation, PTAB cases, SPCs, clinica (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
28.  
 
TRINTELLIX (vortioxetine hydrobromide) Drug Profile, 2025: drug patents, patent challenges, litigation, SPCs, clinical trials, drug prices, annual dru (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

29.  
 
TRIJARDY XR (empagliflozin; linagliptin; metformin hydrochloride) Drug Profile, 2025: TRIJARDY XR (empagliflozin; linagliptin; metformin hydrochloride (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
30.  
 
TIVICAY PD (dolutegravir sodium) Drug Profile, 2025: TIVICAY PD (dolutegravir sodium) drug patents, litigation, SPCs, clinical trials, drug prices, su (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
31.  
 
TIVICAY (dolutegravir sodium) Drug Profile, 2025: TIVICAY (dolutegravir sodium) drug patents, patent challenges, litigation, SPCs, clinical trials, dr (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
32.  
 
TIBSOVO (ivosidenib) Drug Profile, 2025: TIBSOVO (ivosidenib) drug patents, litigation, PTAB cases, SPCs, clinical trials, drug prices, suppliers, API (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

33.  
 
TEPMETKO (tepotinib hydrochloride) Drug Profile, 2025: TEPMETKO (tepotinib hydrochloride) drug patents, SPCs, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
34.  
 
TAZVERIK (tazemetostat hydrobromide) Drug Profile, 2025: TAZVERIK (tazemetostat hydrobromide) drug patents, clinical trials, drug prices, suppliers, A (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
35.  
 
OXLUMO (lumasiran sodium) Drug Profile, 2025: OXLUMO (lumasiran sodium) drug patents, litigation, SPCs, clinical trials, suppliers (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
36.  
 
KISQALI (ribociclib succinate) Drug Profile, 2025: KISQALI (ribociclib succinate) drug patents, litigation, SPCs, clinical trials, drug prices, drug p (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

37.  
 
KENGREAL (cangrelor) Drug Profile, 2025: KENGREAL (cangrelor) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
38.  
 
KALYDECO (ivacaftor) Drug Profile, 2025: KALYDECO (ivacaftor) drug patents, litigation, SPCs, clinical trials, drug prices, suppliers, API sources (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
39.  
 
JULUCA (dolutegravir sodium; rilpivirine hydrochloride) Drug Profile, 2025: JULUCA (dolutegravir sodium; rilpivirine hydrochloride) drug patents, liti (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
40.  
 
JENTADUETO (linagliptin; metformin hydrochloride) Drug Profile, 2025: JENTADUETO (linagliptin; metformin hydrochloride) drug patents, patent challenge (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

41.  
 
JATENZO (testosterone undecanoate) Drug Profile, 2025: JATENZO (testosterone undecanoate) drug patents, litigation, clinical trials, drug prices, drug (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
42.  
 
JANUVIA (sitagliptin phosphate) Drug Profile, 2025: JANUVIA (sitagliptin phosphate) drug patents, patent challenges, litigation, PTAB cases, SPCs, cli (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
43.  
 
JANUMET XR (metformin hydrochloride; sitagliptin phosphate) Drug Profile, 2025: drug patents, patent challenges, litigation, PTAB cases, SPCs, clinica (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
44.  
 
JANUMET (metformin hydrochloride; sitagliptin phosphate) Drug Profile, 2025: drug patents, patent challenges, litigation, PTAB cases, SPCs, clinical t (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

45.  
 
JAKAFI (ruxolitinib phosphate) Drug Profile, 2025: JAKAFI (ruxolitinib phosphate) drug patents, patent challenges, litigation, PTAB cases, SPCs, clini (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
46.  
 
ISENTRESS (raltegravir potassium) Drug Profile, 2025: ISENTRESS (raltegravir potassium) drug patents, patent challenges, SPCs, clinical trials, drug p (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
47.  
 
INVOKAMET XR (canagliflozin; metformin hydrochloride) Drug Profile, 2025: INVOKAMET XR (canagliflozin; metformin hydrochloride) drug patents, litigati (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
48.  
 
INVOKAMET (canagliflozin; metformin hydrochloride) Drug Profile, 2025: INVOKAMET (canagliflozin; metformin hydrochloride) drug patents, patent challen (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)

49.  
 
RYTARY (carbidopa; levodopa) Drug Profile, 2025: RYTARY (carbidopa; levodopa) drug patents, patent challenges, litigation, clinical trials, drug price (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)
50.  
 
RUBRACA (rucaparib camsylate) Drug Profile, 2025: RUBRACA (rucaparib camsylate) drug patents, litigation, SPCs, clinical trials, drug prices, supplier (Paperback)
Drugpatentwatch | Independently Published
376,680원(18% 할인 / 18,840원)


(주)알라딘커뮤니케이션

대표이사 최우경 고객정보보호 책임자 최우경 사업자등록 201-81-23094 통신판매업신고 2003-서울중구-01520 이메일 privacy@aladin.co.kr 호스팅 제공자 알라딘커뮤니케이션 (본사) 서울시 중구 서소문로 89-31
ⓒ Aladin Communication. All Rights Reserved.

고객센터 1544-2514 (발신자 부담)

서울시 마포구 백범로 71 숨도빌딩 7층 Fax 02-6926-2600
1:1 문의 FAQ
중고매장 위치, 영업시간 안내